Abstract
The actions of glucagon-like peptide 1 receptor agonists in the CNS reduce systemic inflammation.
MeSH terms
-
Brain / metabolism
-
Diabetes Mellitus, Type 2*
-
Glucagon-Like Peptide 1*
-
Glucagon-Like Peptide-1 Receptor / agonists
-
Glucagon-Like Peptide-1 Receptor / metabolism
-
Humans
-
Inflammation
Substances
-
Glucagon-Like Peptide 1
-
Glucagon-Like Peptide-1 Receptor